BostonGene-Integrated Genomic Registry (BIGR)
ConditionMalignancy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBostonGene
About this trial
The purpose of this project is to develop a comprehensive database of genomic, transcriptomic, molecular, and clinical characteristics of oncology patients to discover, define, and develop genomic and transcriptomic markers to improve future clinical outcomes across cancer types
Eligibility criteria
Qualifiers
Suspected or confirmed malignancy
Planned comprehensive genomic (> 100 genes) and/or molecular analysis; or genomic and/or molecular data available from prior sequencing
Baseline demographics and treatment information available
Willingness for future contact by BIRG study personnel to provide information regarding associated cancer outcomes and treatment.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov